Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators
Jianping Lu, Juan Xu, Junyi Li, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 19, pp. 10019-10033
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
Ke Zhu, Xiaoqiang Liu, Wen Deng, et al.
Hereditas (2022) Vol. 159, Iss. 1
Open Access | Times Cited: 23
Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types
Zishan Wang, Jiaqi Yin, Weiwei Zhou, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 5, pp. 2287-2302
Open Access | Times Cited: 33
Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Cancer stem cells in brain tumors: From origin to clinical implications
Shuyun Lin, Kaishu Li, Ling Qi
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 11
Exploring novel biomarkers and immunotherapeutic targets for biofeedback therapies to reveal the tumor-associated immune microenvironment through a multimetric analysis of kidney renal clear cell carcinoma
Guobing Wang, Jinbang Huang, Haiqing Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
Jiajia Wang, Yi Sui, Qifeng Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 12
Open Access | Times Cited: 32
Identification of a chromatin regulator signature and potential candidate drugs for primary open-angle glaucoma
Xinyue Zhang, Lulu Xiao, Xiaoyu Zhou, et al.
Epigenomics (2025), pp. 1-11
Open Access
A comprehensive atlas of epigenetic regulators reveals tissue-specific epigenetic regulation patterns
Jilu Wang, Aiai Shi, Jie Lyu
Epigenetics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma
Changzheng Zhang, Jiayi Zeng, Chujin Ye, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 150-172
Open Access | Times Cited: 2
Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer
Yilun Li, Xiaolu Yang, Cuizhi Geng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics
Bo Wang, Yu F, Zhengwei Li, et al.
Life Sciences (2023) Vol. 336, pp. 122312-122312
Open Access | Times Cited: 6
Bioinformatic identification and analysis of immune-related chromatin regulatory genes as potential biomarkers in idiopathic pulmonary fibrosis
Kaixin Li, Pulin Liu, Wei Zhang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 896-896
Open Access | Times Cited: 9
RUVBL1-modulated chromatin remodeling alters the transcriptional activity of oncogenic CTNNB1 in uveal melanoma
Chao Zhang, Shuai Wu
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
Yongbiao Huang, Lingyan Xiao, Motuma Yigezu Daba, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Barasertib impedes chondrocyte senescence and alleviates osteoarthritis by mitigating the destabilization of heterochromatin induced by AURKB
Xunshan Ren, Huangming Zhuang, Fuze Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115343-115343
Open Access | Times Cited: 5
Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
Qihui Wu, Ruotong Tian, Jiaxin Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
Juntao Huang, Ziqian Xu, Zhenzhen Wang, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 804-819
Open Access | Times Cited: 1
Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation
Xinyu Zhang, Xinyue Qin, Tiannan Yu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Development and validation of a chromatin regulator signature for predicting prognosis hepatocellular carcinoma patient
Jiazhen Mao, Fei Song, Yu Zhang, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 397-414
Open Access | Times Cited: 1
Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy
Aiai Shi, Chaohuan Lin, Jie Lyu
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 1
Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer
Kai Song, Hao Cai, Hailong Zheng, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 9
Network analysis with biological data of cancer patients: A scoping review
Alexandra Kosvyra, E. Ntzioni, Ioanna Chouvarda
Journal of Biomedical Informatics (2021) Vol. 120, pp. 103873-103873
Open Access | Times Cited: 9
Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma
Qingtong Shi, Song Han, Xiong Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
CRdb: a comprehensive resource for deciphering chromatin regulators in human
Yimeng Zhang, Yuexin Zhang, Chao Song, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D88-D100
Open Access | Times Cited: 6
GADD45A and GADD45B as Novel Biomarkers Associated with Chromatin Regulators in Renal Ischemia-Reperfusion Injury
Ming Xie, Ruiyan Xie, Pengcheng Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11304-11304
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top